Advertisement
Advertisement
U.S. Markets close in 3 hrs 56 mins
Advertisement
Advertisement
Advertisement
Advertisement

Onconova Therapeutics, Inc. (ONTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.4300+0.0600 (+1.78%)
As of 12:04PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.3700
Open3.3900
Bid3.4100 x 800
Ask3.4300 x 900
Day's Range3.3600 - 3.4500
52 Week Range3.3600 - 28.9500
Volume102,638
Avg. Volume1,904,927
Market Cap811.579M
Beta (5Y Monthly)1.75
PE Ratio (TTM)N/A
EPS (TTM)-0.1450
Earnings DateMar 11, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est20.00
  • American City Business Journals

    Lab notes: Onconova completes $21M stock sale; Waypoint gets $1.7M investment

    This week's look at the Philadelphia region's life sciences industry includes a public stock sale, a private stock sale, a multimillion-dollar research grant and more. Here's the rundown: Onconova The Bucks County-based biopharmaceutical company raised $21 million in a public stock offering. Onconova (NASDAQ: ONTX) of Newtown sold 5 million shares of its common stock at $4.20 per share.

  • GlobeNewswire

    Onconova Therapeutics to Attend the Sachs 21st Annual Biotech in Europe Forum (BEF)

    NEWTOWN, Pa., Sept. 29, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that members of the Company’s management team will be attending the upcoming virtual Sachs 21st Annual Biotech in Europe Forum (BEF) on October 7th and 8th 2021, and will be available for 1x1 meetings from Monday, October 4th through Friday, October 8th. Those register

  • GlobeNewswire

    Onconova Therapeutics, Inc. Announces Closing of $21 Million Public Offering of Common Stock

    NEWTOWN, Pa., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced the closing of its previously announced underwritten public offering. A total of 5,000,000 shares of its common stock were sold at a public offering price of $4.20 per share. The gross proceeds of the offering to the Company are $21 million, before deducti

Advertisement
Advertisement